-
News | 2023.03.03
"Hidden Face of Paris 2023" at the Institut Pasteur: a look back at the event
For the past ten years, the Hidden Face of Paris (Paris Face Cachée) event has been giving the public unique access to more than a hundred sites in the Greater Paris region over a 72-hour period. The idea is simple: members of the public sign up for an adventure based on an evocative title and description, without knowing who is organizing it or who they will meet. The venue is kept secret...
-
Document de presse | 2023.02.21
A blood factor involved in depression
The process of aging is often related to the onset of cognitive decline, depression and memory loss. Scientists from the Institut Pasteur, CNRS and Inserm have discovered that administration of the GDF11 protein, which is known to regenerate murine neural stem cells, improves cognitive abilities and reduces the depressive state in aged mice. They also demonstrated the mechanism of action of this...
-
News | 2023.02.28
Health crises, information crises: exploring the roots of the term "infodemic"
How do the epidemiological and media dimensions of a health crisis fit together? How is the spread of a virus linked to the spread of information about it? Several scientists, communication experts and ethics specialists came together to explore these questions at a conference held at the Institut Pasteur in December.
-
News | 2023.02.20
Earthquake in Turkey: the Institut Pasteur sends scientists to support the relief effort
On a visit to the Institut Pasteur, Chrysoula Zacharopoulou, French Minister of State attached to the Minister for Europe and Foreign Affairs, welcomed the Institut Pasteur's decision to send scientists to help with the relief effort following the earthquake in Turkey. In April 2023, Turkey withdrew its request for assistance to the World Health Organization (WHO) for the deployment of...
-
Document de presse | 2023.03.15
Emergence of extensively drug-resistant Shigella sonnei strain in France
Shigellosis, a highly contagious diarrheal disease, is caused by Shigella bacteria circulating in industrializing countries but also in industrialized countries. Scientists from the French National Reference Center for Escherichia coli, Shigella and Salmonella at the Institut Pasteur who have been monitoring Shigella in France for several years have detected the emergence of extensively drug-...
-
News | 2023.03.22
The origins of SARS-CoV-2: the search goes on
Where did SARS-CoV-2 come from? How did this virus enter the human population? These questions still remain unanswered. In June 2022, a group of experts, the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) commissioned by the World Health Organization (WHO), published a report on the origin of coronavirus but was unable to draw a definitive conclusion. Since then, research has...
-
Document de presse | 2023.03.31
The Institut Pasteur and the University of São Paulo sign articles of association to establish the Institut Pasteur in São Paulo
On Friday March 31st, 2023 at a ceremony in Paris, the Institut Pasteur President, Professor Stewart Cole, and the University of São Paulo (USP) Rector, Carlos Gilberto Carlotti Junior, signed articles of association for the Institut Pasteur in São Paulo, a private non-profit organization under Brazilian law. The mission of the institute, an associate member of the Pasteur Network, is to conduct...
-
Document de presse | 2023.03.31
Professor Yasmine Belkaid appointed Institut Pasteur President
On March 29, 2023, Professor Yasmine Belkaid was appointed President of the Institut Pasteur by its Board of Governors for a six-year term. She will take office in January 2024. A French Algerian born in Algiers in 1968, Professor Yasmine Belkaid is an internationally renowned scientist who has focused her research on the relationship between microbes and the immune system.She began her...
-
Document de presse | 2023.03.07
A New Milestone in the Development of an Effective Allergic Asthma Vaccine
To combat allergic asthma, which affects millions of people worldwide, scientists from Inserm, CNRS and Université Toulouse III-Paul Sabatier at the Infinity laboratory[1], Institut Pasteur and French company NEOVACS are developing and testing a new vaccine. In their previous study, the teams had shown it to be effective in producing antibodies capable of neutralizing human immune proteins that...
-
Document de presse | 2023.03.29
World Autism Awareness Day: Institut Pasteur working actively with clinicians and the autism community
As we mark World Autism Awareness Day on Sunday April 2, 2023, this year the Institut Pasteur is celebrating the 20th anniversary of the discovery of the first genes associated with autism. In 2003, this discovery offered a new perspective on the neurodevelopmental disorder; today, it highlights what still needs to be done to help those affected by autism. Scientists in international consortia...
